Condition
Type I Diabetes Mellitus
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 4 (2)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03406000Phase 4CompletedPrimary
Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL
NCT01467063Not ApplicableCompletedPrimary
Glutamine and Insulin Sensitivity in Type I Diabetes
NCT01868594Phase 4CompletedPrimary
Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
NCT01552603Phase 2CompletedPrimary
Artificial Pancreas Control System in an Inpatient Setting
NCT02126605UnknownPrimary
Accuracy of Blood Glucose Detection by Diabetes Alert Dogs
Showing all 5 trials